Niagen Bioscience (NAGE) shares surged 6.10% in pre-market trading on Thursday, following the company's announcement of a $10 million share repurchase program. This strategic move has sparked investor interest and confidence in the bioscience firm.

The share repurchase program, revealed early Thursday morning, authorizes the company to buy back up to $10 million worth of its outstanding common stock. Such programs are often viewed favorably by investors as they can potentially increase the value of remaining shares and signal management's confidence in the company's financial health and future prospects.

Analysts suggest that this move by Niagen Bioscience could be interpreted as a sign that the company believes its stock is undervalued. The pre-market rally indicates that investors are responding positively to this development, seeing it as a bullish signal for the company's future performance. As the market opens, it remains to be seen how this momentum will carry through the regular trading session.